Found 10 matching trials
A Study to Evaluate the Safety and Ability of the Vaccine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults PHASE1 The purpose of this study is to evaluate the safety and immunogenicity of t...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study to Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine PHASE1 Administration of DPX-RSV(A), a Respiratory Syncytial Virus vaccine contain...
Show More Location
IWK Health Centre
Learn More & Join Trial
RSV-F Vaccine Dose Ranging Study in Young Women PHASE2 The purpose of this study is to evaluate the immunogenicty and safety of an...
Show More Location
Anaheim Clinical Trials
Learn More & Join Trial
A Phase I Randomized, Observer-Blinded, Dose-Ranging Study in Healthy Subjects 24 to <72 Months of Age PHASE1 This is a randomized, observer-blind, irrelevant comparator-controlled tria...
Show More Location
University of Calgary, Alberta Children's Hospital
Learn More & Join Trial
RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly PHASE1 Up to 220 eligible subjects will be enrolled into one of five treatment gro...
Show More Location
Genova Clinical Research
Learn More & Join Trial
RSV F Dose-Ranging Study in Women PHASE2 The purpose of this study is to evaluate the immunogenicity and safety of m...
Show More Location
Diablo Clinical Research
Learn More & Join Trial
A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization PHASE3 The purpose of this study is to determine the efficacy of maternal immuniza...
Show More Location
Research Site US115
Learn More & Join Trial
RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women. PHASE2 The purpose of this study is to evaluate the safety and immunogenicity of a...
Show More Location
Advanced Specialty Research
Learn More & Join Trial
Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults PHASE1 Background:
Respiratory Syncytial Virus (RSV) is a virus that infects the ...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Safety and Immunogenicity Study to Evaluate Single- or Two-Dose Regimens Of RSV F Vaccine With and Without Aluminum Phosphate or Matrix-M1™ Adjuvants In Clinically-Stable Older Adults PHASE2 This is a randomized, observer-blind, trial in clinically-stable older adul...
Show More Location
Research Site AU004
Learn More & Join Trial